1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
    Journal Article

    Li, D.; Pant, S.; Ryan, D. P.; Laheru, D.; Bahary, N.; Dragovich, T.; Hosein, P. J.; Rolfe, L.; Saif, M. W.; Lavalle, J.; more...
    Pancreatology (2014)

    Fulltext@MSK | Save
  • Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): Results from the dose-finding portion of a phase 1/2 study
    Journal Article

    Gadgeel, S. M.; Gandhi, L.; Riely, G. J.; Chiappori, A. A.; West, H. L.; Azada, M. C.; Morcos, P. N.; Lee, R. M.; Garcia, L.; Yu, L.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
    Journal Article

    de Azambuja, E.; Holmes, A. P.; Piccart-Gebhart, M.; Holmes, E.; Di Cosimo, S.; Swaby, R. F.; Untch, M.; Jackisch, C.; Lang, I.; Smith, I.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Diminishing relative contraindications for immediate breast reconstruction: A multicenter study
    Journal Article

    Albornoz, C. R.; Cordeiro, P. G.; Pusic, A. L.; McCarthy, C. M.; Mehrara, B. J.; Disa, J. J.; Matros, E.
    Journal of the American College of Surgeons (2014)

    Fulltext@MSK | Save
  • A multicenter phase l/ll study of obatoclax mesylate administered as a 3- Or 24-hour infusion in older patients with previously untreated acute myeloid leukemia
    Journal Article

    Schimmer, A. D.; Raza, A.; Carter, T. H.; Claxton, D.; Erba, H.; DeAngelo, D. J.; Tallman, M. S.; Goard, C.; Borthakur, G.
    PLoS ONE (2014)

    Fulltext@MSK | Save
  • Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: A multicenter retrospective analysis
    Journal Article

    Petrich, A. M.; Gandhi, M.; Jovanovic, B.; Castillo, J. J.; Rajguru, S.; Yang, D. T.; Shah, K. A.; Whyman, J. D.; Lansigan, F.; Hernandez-Ilizaliturri, F. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Sun exposure and melanoma survival: A GEM study
    Journal Article

    Berwick, M.; Reiner, A. S.; Paine, S.; Armstrong, B. K.; Kricker, A.; Goumas, C.; Cust, A. E.; Thomas, N. E.; Groben, P. A.; From, L.; more...
    Cancer Epidemiology Biomarkers and Prevention (2014)

    Fulltext@MSK | Save
  • Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Barrios, C. H.; Kim, T. M.; Falcon, S.; Cosgriff, T.; Harker, W. G.; Srimuninnimit, V.; Pittman, K.; Sabbatini, R.; Rha, S. Y.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: A non-randomised, phase 1b study
    Journal Article

    Younes, A.; Thieblemont, C.; Morschhauser, F.; Flinn, I.; Friedberg, J. W.; Amorim, S.; Hivert, B.; Westin, J.; Vermeulen, J.; Bandyopadhyay, N.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Daughters and Mothers Against Breast Cancer (DAMES): Main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters
    Journal Article

    Demark-Wahnefried, W.; Jones, L. W.; Snyder, D. C.; Sloane, R. J.; Kimmick, G. G.; Hughes, D. C.; Badr, H. J.; Miller, P. E.; Burke, L. E.; Lipkus, I. M.
    Cancer (2014)

    Fulltext@MSK | Save